Back to search
FDAFDA · Food and drugs·Recall number Z-2742-2026

Photera 400, phototherapy device; Ultraviolet Lamp For Dermatologic Disorders

Published July 22, 2026 · Recall initiated: March 5, 2026

Summary

FDA records medical device Class II recall Z-2742-2026, published July 22, 2026 and initiated March 5, 2026. Recalling firm: Daavlin Distributing Company; Status: Ongoing; Reported quantity: 2 units; Lot: Serial Numbers: 4-01440NB10CL, 2 4-01441NB10CL. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Calibrated Output was not calculating correctly - UV Sensor GAIN being applied was incorrect - GAIN seemed to be "4/5" instead of "7" (counts were at ~1000 instead of ~5000).

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Daavlin Distributing Company
Distributor
US Nationwide distribution.
Lot
Serial Numbers: 4-01440NB10CL, 2 4-01441NB10CL.
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Photera 400, phototherapy device; Ultraviolet Lamp For Dermatologic Disorders recalled?

Yes. FDA published recall Z-2742-2026 on July 22, 2026. Reported hazard: Calibrated Output was not calculating correctly - UV Sensor GAIN being applied was incorrect - GAIN seemed to be "4/5" instead of "7" (counts were at ~1000 instead of ~5000).

What should I do if I have this product?

Voluntary: Firm initiated · Telephone